RK

Rajive Kumar

Director Director DIN 02399932
DIN 02399932 First appointment Sep 2008 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Sep 2008
Shareholding value •••• Premium profile

About Rajive Kumar

Data last updated:

Rajive Kumar was a Director at Indra Diagnostic Centre And Blood Bank Limited (2008–2017) and Director at Chandan Pharmacy Limited (2019–2022). The companies operate in Healthcare and Pharma.

DIN 02399932
Primary Designation Director
Industry Healthcare
First Appointment 29 Sep 2008

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 Sep 20081992₹61,000 (FY 2025)Active
Chandan Pharmacy Limited U47721UP2017PLC193492
Director11 Oct 20192017₹59.10 Cr (FY 2023)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Indra Diagnostic Centre And Blood Bank Limited
Chandan Pharmacy Limited
Premium access

Shareholding and investment profile for Rajive Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajive Kumar

Rajive Kumar was first appointed on 29 Sep 2008 as Director at Indra Diagnostic Centre And Blood Bank Limited. The most recent appointment on record is 11 Oct 2019 at Chandan Pharmacy Limited.

Rajive Kumar held 2 earlier board appointments: Indra Diagnostic Centre And Blood Bank Limited (Director, 29 Sep 2008 to 18 Apr 2017); Chandan Pharmacy Limited (Director, 11 Oct 2019 to 26 Feb 2022).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available